Union Bancaire Privee’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Union Bancaire Privee’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75	Hold	175	–	–	﹤0.01%	483
2026 Q1	$74	Hold	175	–	–	﹤0.01%	479
2025 Q4	$73	Hold	175	–	–	﹤0.01%	488
2025 Q3	$73	Hold	175	–	–	﹤0.01%	477
2025 Q2	$74	Buy	+175	New	+$74	﹤0.01%	490

Union Bancaire Privee's ONCT Position: Q2 2026 in Review

Union Bancaire Privee held its Oncternal Therapeutics, Inc. Common Stock (ONCT) position steady in Q2 2026 at 175 shares worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #483.

Union Bancaire Privee first reported a position in ONCT in Q2 2025 and has held it in 5 quarters since. 1 fund tracked by Wall St. Rank holds ONCT as of Q2 2026.

Union Bancaire Privee held 175 shares of Oncternal Therapeutics, Inc. Common Stock worth $75 as of Q2 2026.
Union Bancaire Privee left its Oncternal Therapeutics, Inc. Common Stock share count unchanged in Q2 2026.
Oncternal Therapeutics, Inc. Common Stock made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #483 holding.
Union Bancaire Privee first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2025 and has held it in 5 quarters since.
1 fund tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.